Informação sobre produto
- UK-81252
- beta-Alanine, 2-((1-(((1-carboxy-2-(4-hydroxyphenyl)ethyl)amino)carbonyl)cyclopentyl)methyl)-N-(N2-(methylsulfonyl)-L-lysyl)-, (S-(R*,R*))-
- N-({1-[(2R)-3-carboxy-2-{[N~2~-(methylsulfonyl)-L-lysyl]amino}propyl]cyclopentyl}carbonyl)-L-tyrosine
- L-Tyrosine, N2-(methylsulfonyl)-L-lysyl-1-[(2S)-3-amino-2-carboxypropyl]cyclopentanecarbonyl-
- N-(1-(2-Carboxy-3-(N(2)-mesyllysylamino)propyl)-1-cyclopentylcarbonyl)tyrosine
- (S-(R*,R*))-2-((1-(((1-Carboxy-2-(4-hydroxyphenyl)ethyl)amino)carbonyl)cyclopentyl)methyl)-N-(N2-(methylsulfonyl)-L-lysyl)-beta-Alanine
- UK 81252
- β-Alanine, 2-[[1-[[[1-carboxy-2-(4-hydroxyphenyl)ethyl]amino]carbonyl]cyclopentyl]methyl]-N-[N2-(methylsulfonyl)-L-lysyl]-, [S-(R*,R*)]-
- N2-(Methylsulfonyl)-L-lysyl-1-[(2S)-3-amino-2-carboxypropyl]cyclopentanecarbonyl-L-tyrosine
- N-((1-((S)-3-((S)-6-Amino-2-methanesulfonamidohexanamido)-2-carboxypropyl)cyclopentyl)carbonyl)-L-tyrosine
- Ver mais sinónimos
- UK 81,252
Sampatrilat, an oral vasopeptidase inhibitor, more potently blocks C-domain ACE (Ki=13.8 nM) over N-domain (Ki=171.9 nM).
Propriedades químicas
Consulta técnica sobre: TM-T16840 Sampatrilat
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.